FDA Approved: LUMIZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for Lumizyme (alglucosidase alfa) from Genzyme Corporation. The action pertains to Pompe disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• LUMIZYME (ALGLUCOSIDASE ALFA)

Snippet

SUPPL AP for LUMIZYME (ALGLUCOSIDASE ALFA)